Ryder System Inc R shares are trading lower on Thursday after it reported third-quarter results.
Sales grew 8% year-on-year to $3.17 billion, missing the analyst consensus estimate of $3.29 billion.
Revenue from Fleet Management Solutions fell 1% to $1.47 billion, Supply Chain Solutions climbed 10% to $1.317 billion and Dedicated Transportation Solutions jumped 41% to $633 million.
Earnings before tax declined to $188 million from $213 million a year ago quarter. Adjusted EPS of $3.44 beat the analyst consensus of $3.42.
Operating cash flow for nine months totaled $1.7 billion, with a free cash flow of $218 million. Ryder System held $162 million in cash and equivalents as of September-end.
The company’s board recently authorized a new discretionary 2 million share repurchase program that replaces the recently completed program.
Ryder Chairman & CEO Robert Sanchez said, “We saw double-digit earnings growth in our contractual businesses. Higher ChoiceLease results from our pricing and maintenance initiatives benefited FMS. Stronger operating performance and cost-management actions benefited SCS. DTS delivered strong earnings growth, demonstrating the resiliency of our legacy business. Each of the segments also benefited from recent acquisitions.”
“The long-term secular growth trends remain intact for all of our contractual businesses, although we are experiencing near-term sales headwinds that reflect the extended freight downturn and overall economic uncertainty.”
Outlook: Ryder lowered its FY24 operating revenue growth to ~7% (vs. ~8% prior) and tightened the adjusted EPS forecast to $11.90 – $12.10 (vs. consensus of $12.13) from $11.90 – $12.40 earlier.
For the fourth quarter, Ryder sees adjusted EPS of $3.32 – $3.52 against the consensus of $3.57.
Investors can gain exposure to the stock via First Trust Nasdaq Transportation ETF FTXR and SPDR S&P Transportation ETF XTN.
Price Action: R shares are down 4.36% at $138.71 at the last check Thursday.
Read Next:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.